Serina Therapeutics, Inc. (SER)
NYSEAMERICAN: SER · Real-Time Price · USD
1.980
-0.020 (-1.00%)
At close: Apr 10, 2026, 4:00 PM EDT
1.950
-0.030 (-1.52%)
Pre-market: Apr 13, 2026, 6:03 AM EDT

Serina Therapeutics Stock Forecast

SER's stock price has decreased by -60.71% in the past year and price targets may not have had time to catch up.

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Serina Therapeutics stock has a target of 15, which predicts a 657.58% increase from the current stock price of 1.98.

Price Target: $15 (+657.58%)
Analyst Consensus: Strong Buy
TargetLowAverageMedianHigh
Price$15$15$15$15
Change+657.58%+657.58%+657.58%+657.58%
* Price targets were last updated on Aug 28, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for Serina Therapeutics is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

RatingJan '26Feb '26Mar '26Apr '26
Strong Buy2221
Buy0000
Hold0000
Sell0000
Strong Sell0000
Total2221

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$15
Strong BuyReiterates$15+657.58%Aug 28, 2025
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Initiates
$15
Strong BuyInitiates$15+657.58%Jul 14, 2025
Jones Trading
Jones Trading
Strong Buy
Initiates
$11
Strong BuyInitiates$11+455.56%Mar 11, 2025

Financial Forecast

Revenue This Year
n/a
from 130.00K
Revenue Next Year
n/a
EPS This Year
-1.42
from -1.91
EPS Next Year
-1.06
from -1.42
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
3.46M591.50K3.15M56.00K130.00K--
Revenue Growth
--82.93%433.05%-98.22%132.14%--
EPS
-0.59-1.250.72-1.51-1.91-1.42-1.06
EPS Growth
-------
Forward PE
-------
No. Analysts
-----32
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue20262027202820292030
Highn/an/a
Avgn/an/a
Lown/an/a

Revenue Growth

Revenue Growth20262027202820292030
High--
Avg--
Low--

EPS Forecast

EPS20262027202820292030
High-1.48-1.10
Avg-1.42-1.06
Low-1.38-1.03

EPS Growth

EPS Growth20262027202820292030
High--
Avg--
Low--
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.